Mechanisms of NOS1AP action on NMDA receptor-nNOS signaling

Frontiers in Cellular Neuroscience

Volumn 8, Issue AUG, 2014, Pages

  Courtney, Michael J ^a,b   Li, Li Li ^a   Lai, Yvonne Y ^c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b TURKU CENTRE FOR BIOTECHNOLOGY   (Finland)

^c INDIANA UNIVERSITY   (United States)

Author keywords

Excitotoxicity; Nitric oxide; NMDA receptor; NNOS; NOS1AP; PDZ; PSD95; Schizophrenia

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE 1 ADAPTOR PROTEIN; PEPTIDES AND PROTEINS; POSTSYNAPTIC DENSITY PROTEIN 95; UNCLASSIFIED DRUG;

BINDING AND RELATED PHENOMENA; CALCIUM TRANSPORT; CEREBROVASCULAR ACCIDENT; CHRONIC PAIN; CLINICAL TRIAL (TOPIC); DELAYED RELEASE MODEL; DEPRESSION; EXCITOTOXICITY; EXCLUSION MODEL; HUMAN; MODEL; NERVE DEGENERATION; REVIEW; SCAFFOLD MODEL; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; TWO STATE MODEL;

EID: 84910026507     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00252     Document Type: Review

References (58)

1. Aarts, M., Liu, Y., Liu, L., Besshoh, S., Arundine, M., Gurd, J. W., et al. (2002). Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions. Science 298, 846-850. doi: 10.1126/science.1072873
2. Alchera, E., Dal Ponte, C., Imarisio, C., Albano, E., and Carini, R. (2010). Molecular mechanisms of liver preconditioning. World J. Gastroenterol. 16, 6058-6067. doi: 10.3748/wjg.v16.i48.6058
3. Becker, M. L., Visser, L. E., Newton-Cheh, C., Witteman, J. C., Hofman, A., Uitterlinden, A. G., et al. (2008). Genetic variation in the NOS1AP gene is associated with the incidence of diabetes mellitus in users of calcium channel blockers. Diabetologia 51, 2138-2140. doi: 10.1007/s00125-008-1143-4
4. Blazer, L. L., and Neubig, R. R. (2009). Small molecule protein-protein interaction inhibitors as CNS therapeutic agents: current progress and future hurdles. Neuropsychopharmacology 34, 126-141. doi: 10.1038/npp.2008.151
5. Brecht, S., Kirchhof, R., Chromik, A., Willesen, M., Nicolaus, T., Raivich, G., et al. (2005). Specific pathophysiological functions of JNK isoforms in the brain. Eur. J. Neurosci. 21, 363-377. doi: 10.1111/j.1460-9568.2005.03857.x
6. Brenman, J. E., Chao, D. S., Gee, S. H., McGee, A. W., Craven, S. E., Santillano, D. R., et al. (1996). Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains. Cell 84, 757-767. doi: 10.1016/s0092-8674(00)81053-3
7. Brzustowicz, L. M., Simone, J., Mohseni, P., Hayter, J. E., Hodgkinson, K. A., Chow, E. W., et al. (2004). Linkage disequilibrium mapping of schizophrenia susceptibility to the CAPON region of chromosome 1q22. Am. J. Hum. Genet. 74, 1057-1063. doi: 10.1086/420774
8. Cao, J., Semenova, M. M., Solovyan, V. T., Han, J., Coffey, E. T., and Courtney, M. J. (2004). Distinct requirements for p38alpha and c-Jun N-terminal kinase stress-activated protein kinases in different forms of apoptotic neuronal death. J. Biol. Chem. 279, 35903-35913. doi: 10.1074/jbc.m402353200
9. Cao, J., Viholainen, J. I., Dart, C., Warwick, H. K., Leyland, M. L., and Courtney, M. J. (2005). The PSD95-nNOS interface: a target for inhibition of excitotoxic p38 stress-activated protein kinase activation and cell death. J. Cell Biol. 168, 117-126. doi: 10.1083/jcb.200407024
10. Carrel, D., Du, Y., Komlos, D., Hadzimichalis, N. M., Kwon, M., Wang, B., et al. (2009). NOS1AP regulates dendrite patterning of hippocampal neurons through a carboxypeptidase E-mediated pathway. J. Neurosci. 29, 8248-8258. doi: 10.1523/JNEUROSCI.5287-08.2009
11. Cheah, J. H., Kim, S. F., Hester, L. D., Clancy, K. W., Patterson, S. E. 3rd, Papadopoulos, V., et al. (2006). NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1. Neuron 51, 431-440. doi: 10.1016/j.neuron.2006.07.011
12. Chen, J., Pan, L., Wei, Z., Zhao, Y., and Zhang, M. (2008). Domain-swapped dimerization of ZO-1 PDZ2 generates specific and regulatory connexin43-binding sites. EMBO J. 27, 2113-2123. doi: 10.1038/emboj.2008.138
13. Christopherson, K. S., Hillier, B. J., Lim, W. A., and Bredt, D. S. (1999). PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J. Biol. Chem. 274, 27467-27473. doi: 10.1074/jbc.274.39.27467
14. Citrome, L. (2014). Unmet needs in the treatment of schizophrenia: new targets to help different symptom domains. J. Clin. Psychiatry 75(Suppl. 1), 21-26. doi: 10.4088/jcp.13049su1c.04
15. Courtney, M. J., and Nicholls, D. G. (1992). Interactions between phospholipase C-coupled and N-methyl-D-aspartate receptors in cultured cerebellar granule cells: protein kinase C mediated inhibition of N-methyl-D-aspartate responses. J. Neurochem. 59, 983-992. doi: 10.1111/j.1471-4159.1992.tb08339.x
16. Dau, A., Gladding, C. M., Sepers, M. D., and Raymond, L. A. (2014). Chronic blockade of extrasynaptic NMDA receptors ameliorates synaptic dysfunction and pro-death signaling in Huntington disease transgenic mice. Neurobiol. Dis. 62, 533-542. doi: 10.1016/j.nbd.2013.11.013
17. Delorme, R., Betancur, C., Scheid, I., Anckarsäter, H., Chaste, P., Jamain, S., et al. (2010). Mutation screening of NOS1AP gene in a large sample of psychiatric patients and controls. BMC Med. Genet. 11:108. doi: 10.1186/1471-2350-11-108
18. Doucet, M. V., Harkin, A., and Dev, K. K. (2012). The PSD-95/nNOS complex: new drugs for depression? Pharmacol. Ther. 133, 218-229. doi: 10.1016/j.pharmthera.2011.11.005
19. Doyle, D. A., Lee, A., Lewis, J., Kim, E., Sheng, M., and MacKinnon, R. (1996). Crystal structures of a complexed and peptide-free membrane protein-binding domain: molecular basis of peptide recognition by PDZ. Cell 85, 1067-1076. doi: 10.1016/s0092-8674(00)81307-0
20. Eastwood, S. L. (2005). Does the CAPON gene confer susceptibility to schizophrenia? PLoS Med. 2:e348. doi: 10.1371/journal.pmed.0020348
21. Fang, M., Jaffrey, S. R., Sawa, A., Ye, K., Luo, X., and Snyder, S. H. (2000). Dexras1: a G protein specifically coupled to neuronal nitric oxide synthase via CAPON. Neuron 28, 183-193. doi: 10.1016/S0896-6273(00)00095-7
22. Florio, S. K., Loh, C., Huang, S. M., Iwamaye, A. E., Kitto, K. F., Fowler, K. W., et al. (2009). Disruption of nNOS-PSD95 protein-protein interaction inhibits acute thermal hyperalgesia and chronic mechanical allodynia in rodents. Br. J. Pharmacol. 158, 494-506. doi: 10.1111/j.1476-5381.2009.00300.x
23. Ghatan, S., Larner, S., Kinoshita, Y., Hetman, M., Patel, L., Xia, Z., et al. (2000). p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons. J. Cell Biol. 150, 335-347. doi: 10.1083/jcb.150.2.335
24. Hardingham, G. E., and Bading, H. (2010). Synaptic versus extrasynaptic NMDA receptor signaling: implications for neurodegenerative disorders. Nat. Rev. Neurosci. 11, 682-696. doi: 10.1038/nrn2911
25. Harris, B. Z., and Lim, W. A. (2001). Mechanism and role of PDZ domains in signaling complex assembly. J. Cell Sci.114, 3219-3231.
26. Hashimoto, K. (2009). Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Res. Rev. 61, 105-123. doi: 10.1016/j.brainresrev.2009.05.005
27. Hausenloy, D. J., and Yellon, D. M. (2006). Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc. Res. 70, 240-253. doi: 10.1016/j.cardiores.2006.01.017
28. Hill, M. D., Martin, R. H., Mikulis, D., Wong, J. H., Silver, F. L., Terbrugge, K. G., et al. (2012). Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 11, 942-950. doi: 10.1016/S1474-4422(12)70225-9
29. Hillier, B. J., Christopherson, K. S., Prehoda, K. E., Bredt, D. S., and Lim, W. A. (1999). Unexpected modes of PDZ domain scaffolding revealed by structure of nNOS-syntrophin complex. Science 284, 812-815. doi: 10.1126/science.284.5415.812
30. Ishii, H., Shibuya, K., Ohta, Y., Mukai, H., Uchino, S., Takata, N., et al. (2006). Enhancement of nitric oxide production by association of nitric oxide synthase with N-methyl-D-aspartate receptors via postsynaptic density 95 in genetically engineered Chinese hamster ovary cells: real-time fluorescence imaging using nitric oxide sensitive dye. J. Neurochem. 96, 1531-1539. doi: 10.1111/j.1471-4159.2006.03656.x
31. Jaffrey, S. R., Snowman, A. M., Eliasson, M. J., Cohen, N. A., and Snyder, S. H. (1998). CAPON: a protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95. Neuron 20, 115-124. doi: 10.1016/s0896-6273(00)80439-0
32. Ji, R. R., Gereau, R. W. 4th, Malcangio, M., and Strichartz, G. R. (2009). MAP kinase and pain. Brain Res. Rev. 60, 135-148. doi: 10.1016/j.brainresrev.2008.12.011
33. Kapoor, A., Sekar, R. B., Hansen, N. F., Fox-Talbot, K., Morley, M., Pihur, V., et al. (2014). An enhancer polymorphism at the cardiomyocyte intercalated disc protein NOS1AP locus is a major regulator of the QT interval. Am. J. Hum. Genet. 94, 854-869. doi: 10.1016/j.ajhg.2014.05.001
34. Kemp, J. A., and McKernan, R. M. (2002). NMDA receptor pathways as drug targets. Nat. Neurosci. 5, 1039-1042. doi: 10.1038/nn936
35. Keynes, R. G., Duport, S., and Garthwaite, J. (2004). Hippocampal neurons in organotypic slice culture are highly resistant to damage by endogenous and exogenous nitric oxide. Eur. J. Neurosci. 19, 1163-1173. doi: 10.1111/j.1460-9568.2004.03217.x
36. Lai, T. W., Zhang, S., and Wang, Y. T. (2014). Excitotoxicity and stroke: identifying novel targets for neuroprotection. Prog. Neurobiol. 115, 157-188. doi: 10.1016/j.pneurobio.2013.11.006
37. Lawford, B. R., Morris, C. P., Swagell, C. D., Hughes, I. P., Young, R. M., and Voisey, J. (2013). NOS1AP is associated with increased severity of PTSD and depression in untreated combat veterans. J. Affect. Disord. 147, 87-93. doi: 10.1016/j.jad.2012.10.013
38. Lee, H. J., and Zheng, J. J. (2010). PDZ domains and their binding partners: structure, specificity and modification. Cell Commun. Signal. 8:8. doi: 10.1186/1478-811x-8-8
39. Lenfant, N., Polanowska, J., Bamps, S., Omi, S., Borg, J. P., and Reboul, J. (2010). A genome-wide study of PDZ-domain interactions in C elegans reveals a high frequency of non-canonical binding. BMC Genomics 11:671. doi: 10.1186/1471-2164-11-671
40. Li, L. L., Ginet, V., Liu, X., Vergun, O., Tuittila, M., Mathieu, M., et al. (2013). The nNOS-p38MAPK pathway is mediated by NOS1AP during neuronal death. J. Neurosci. 33, 8185-8201. doi: 10.1523/JNEUROSCI.4578-12.2013
41. Mellone, M., and Gardoni, F. (2013). Modulation of NMDA receptor at the synapse: promising therapeutic interventions in disorders of the nervous system. Eur. J. Pharmacol. 719, 75-83. doi: 10.1016/j.ejphar.2013.04.054
42. Mukherjee, P., Cinelli, M. A., Kang, S., and Silverman, R. B. (2014). Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain. Chem. Soc. Rev. doi: 10.1039/c3cs60467e. [Epub ahead of print].
43. Newton-Cheh, C., Eijgelsheim, M., Rice, K. M., de Bakker, P. I., Yin, X., Estrada, K., et al. (2009). Common variants at ten loci influence QT interval duration in the QTGEN study. Nat. Genet. 41, 399-406. doi: 10.1038/ng.364
44. Park, H. S., Huh, S. H., Kim, M. S., Lee, S. H., and Choi, E. J. (2000). Nitric oxide negatively regulates c-Jun N-terminal kinase/stress-activated protein kinase by means of S-nitrosylation. Proc. Natl. Acad. Sci. U S A 97, 14382-14387. doi: 10.1073/pnas.97.26.14382
45. Philippides, A., Ott, S. R., Husbands, P., Lovick, T. A., and O'Shea, M. (2005). Modeling cooperative volume signaling in a plexus of nitric-oxide-synthase-expressing neurons. J. Neurosci. 25, 6520-6532. doi: 10.1523/jneurosci.1264-05.2005
46. Qin, W., Zhang, R., Hu, C., Wang, C. R., Lu, J. Y., Yu, W. H., et al. (2010). A variation in NOS1AP gene is associated with repaglinide efficacy on insulin resistance in type 2 diabetes of Chinese. Acta Pharmacol. Sin. 31, 450-454. doi: 10.1038/aps.2010.25
47. Rajashekaran, P., Pai, K., Thunga, R., and Unnikrishnan, B. (2013). Post-stroke depression and lesion location: a hospital based cross-sectional study. Indian J. Psychiatry 55, 343-348. doi: 10.4103/0019-5545.120546
48. Salter, M. W., and Pitcher, G. M. (2012). Dysregulated Src upregulation of NMDA receptor activity: a common link in chronic pain and schizophrenia. FEBS J. 279, 2-11. doi: 10.1111/j.1742-4658.2011.08390.x
49. Soriano, F. X., Martel, M. A., Papadia, S., Vaslin, A., Baxter, P., Rickman, C., et al. (2008). Specific targeting of pro-death NMDA receptor signals with differing reliance on the NMDAR2B PDZ ligand. J. Neurosci. 28, 10696-10710. doi: 10.1523/JNEUROSCI.1207-08.2008
50. Stein, T. D., Alvarez, V. E., and McKee, A. C. (2014). Chronic traumatic encephalopathy: a spectrum of neuropathological changes following repetitive brain trauma in athletes and military personnel. Alzheimers Res. Ther. 6:4. doi: 10.1186/alzrt234
51. Tochio, H., Mok, Y. K., Zhang, Q., Kan, H. M., Bredt, D. S., and Zhang, M. (2000). Formation of nNOS/PSD-95 PDZ dimer requires a preformed beta-finger structure from the nNOS PDZ domain. J. Mol. Biol. 303, 359-370. doi: 10.1006/jmbi.2000.4148
52. Tochio, H., Zhang, Q., Mandal, P., Li, M., and Zhang, M. (1999). Solution structure of the extended neuronal nitric oxide synthase PDZ domain complexed with an associated peptide. Nat. Struct. Biol. 6, 417-421. doi: 10.1038/8216
53. Vu, N. Q., and Aizenstein, H. J. (2013). Depression in the elderly: brain correlates, neuropsychological findings and role of vascular lesion load. Curr. Opin. Neurol. 26, 656-661. doi: 10.1097/WCO.0000000000000028
54. Wang, C. K., Pan, L., Chen, J., and Zhang, M. (2010). Extensions of PDZ domains as important structural and functional elements. Protein Cell 1, 737-751. doi: 10.1007/s13238-010-0099-6
55. Weber, H., Klamer, D., Freudenberg, F., Kittel-Schneider, S., Rivero, O., Scholz, C. J., et al. (2014). The genetic contribution of the NO system at the glutamatergic post-synapse to schizophrenia: further evidence and meta-analysis. Eur. Neuropsychopharmacol. 24, 65-85. doi: 10.1016/j.euroneuro.2013.09.005
56. Xu, B., Wratten, N., Charych, E. I., Buyske, S., Firestein, B. L., and Brzustowicz, L. M. (2005). Increased expression in dorsolateral prefrontal cortex of CAPON in schizophrenia and bipolar disorder. PLoS Med. 2:e263. doi: 10.1371/journal.pmed.0020263
57. Zhao, L., Liu, X., Liang, J., Han, S., Wang, Y., Yin, Y., et al. (2013). Phosphorylation of p38 MAPK mediates hypoxic preconditioning-induced neuroprotection against cerebral ischemic injury via mitochondria translocation of Bcl-xL in mice. Brain Res. 1503, 78-88. doi: 10.1016/j.brainres.2013.01.051
58. Zhou, L., Li, F., Xu, H. B., Luo, C. X., Wu, H. Y., Zhu, M. M., et al. (2010). Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95. Nat. Med. 16, 1439-1443. doi: 10.1038/nm.2245